Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ifenprodil for methamphetamine dependence
jRCTs031180080Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ifenprodil in stimulant use disorder (SUD) and methamphetamine use disorder (MUD) (3 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Methamphetamine use during treatment. Started Jan 2018; status: completed.
02
Drugs
ifenprodil
03
Conditions
stimulant use disorder (SUD)methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on jRCTs031180080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180080.